Invesco
QTTB icon

Invesco’s Q32 Bio QTTB Stock Holding History

Invesco’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-876
Closed -$48K – 4163
2022
Q1 		$48K Sell
876
-904
-51% -$56.1K ﹤0.01% 3933
2021
Q4 		$116K Sell
1,780
-351
-16% -$34.1K ﹤0.01% 3879
2021
Q3 		$302K Buy
2,131
+126
+6% +$16.1K ﹤0.01% 3651
2021
Q2 		$262K Buy
2,005
+647
+48% +$80.7K ﹤0.01% 3685
2021
Q1 		$230K Buy
+1,358
New +$286K ﹤0.01% 3644
2020
Q2 		– Sell
-1,937
Closed -$542K – 3698
2020
Q1 		$542K Buy
+1,937
New +$593K ﹤0.01% 3018
2019
Q1 		– Sell
-2,236
Closed -$900K – 3841
2018
Q4 		$900K Buy
+2,236
New +$846K ﹤0.01% 3033

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco's QTTB Position: Q2 2022 in Review

Invesco sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 876 shares — an estimated $48K sold.

Invesco first reported a position in QTTB in Q4 2018 and held it in 7 quarters. The position peaked at $900K in Q4 2018. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • Invesco reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 876 Q32 Bio shares in Q2 2022, an estimated $48K.
  • Invesco first reported a position in Q32 Bio in Q4 2018 and held it in 7 quarters.
  • Invesco's Q32 Bio position peaked at $900K in Q4 2018.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.